Ms. Cupples brings extensive global commercial leadership and rare disease product launch experience Newton, Massachusetts, June 9, 2025 – Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced the appointment of Courtney Cupples as Chief Commercial Officer (CCO). Ms.